

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.99951311 |
| 2 | vocalization behavior (GO:0071625) | 5.74389959 |
| 3 | behavioral response to nicotine (GO:0035095) | 5.64170981 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.57149876 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.54653052 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.48323560 |
| 7 | locomotory exploration behavior (GO:0035641) | 5.42746212 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.39548103 |
| 9 | synaptic vesicle maturation (GO:0016188) | 5.26451398 |
| 10 | glutamate secretion (GO:0014047) | 5.17608195 |
| 11 | protein localization to synapse (GO:0035418) | 5.12578439 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.10820478 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.02065068 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.90137805 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.88935216 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 4.79477900 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.63129892 |
| 18 | glutamate receptor signaling pathway (GO:0007215) | 4.62587717 |
| 19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.57709707 |
| 20 | exploration behavior (GO:0035640) | 4.55900831 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.45373109 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.41683681 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.40430189 |
| 24 | regulation of synaptic vesicle transport (GO:1902803) | 4.39252384 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.32852884 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.31969997 |
| 27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.29954057 |
| 28 | layer formation in cerebral cortex (GO:0021819) | 4.09783630 |
| 29 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.06291626 |
| 30 | positive regulation of synapse maturation (GO:0090129) | 4.05769781 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.03690934 |
| 32 | regulation of synapse structural plasticity (GO:0051823) | 4.00578082 |
| 33 | dendritic spine morphogenesis (GO:0060997) | 3.99775398 |
| 34 | neuron recognition (GO:0008038) | 3.96942273 |
| 35 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.91679700 |
| 36 | regulation of postsynaptic membrane potential (GO:0060078) | 3.89867658 |
| 37 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.88042232 |
| 38 | long-term memory (GO:0007616) | 3.85012328 |
| 39 | gamma-aminobutyric acid transport (GO:0015812) | 3.82819756 |
| 40 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.73393891 |
| 41 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.73296411 |
| 42 | long-term synaptic potentiation (GO:0060291) | 3.73236236 |
| 43 | regulation of synaptic plasticity (GO:0048167) | 3.72487645 |
| 44 | positive regulation of membrane potential (GO:0045838) | 3.71147046 |
| 45 | presynaptic membrane assembly (GO:0097105) | 3.69730107 |
| 46 | postsynaptic membrane organization (GO:0001941) | 3.68352135 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.66434226 |
| 48 | cellular potassium ion homeostasis (GO:0030007) | 3.65057339 |
| 49 | axonal fasciculation (GO:0007413) | 3.64612751 |
| 50 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.63476543 |
| 51 | synaptic vesicle endocytosis (GO:0048488) | 3.60894390 |
| 52 | proline transport (GO:0015824) | 3.59424777 |
| 53 | response to histamine (GO:0034776) | 3.57707574 |
| 54 | neurotransmitter transport (GO:0006836) | 3.56858920 |
| 55 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.52431408 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.49878041 |
| 57 | transmission of nerve impulse (GO:0019226) | 3.47309429 |
| 58 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.45971735 |
| 59 | presynaptic membrane organization (GO:0097090) | 3.45159738 |
| 60 | cell differentiation in hindbrain (GO:0021533) | 3.41688173 |
| 61 | nucleobase catabolic process (GO:0046113) | 3.40664015 |
| 62 | behavioral fear response (GO:0001662) | 3.39703880 |
| 63 | behavioral defense response (GO:0002209) | 3.39703880 |
| 64 | behavioral response to cocaine (GO:0048148) | 3.36220251 |
| 65 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.35906217 |
| 66 | cerebellar granule cell differentiation (GO:0021707) | 3.35087271 |
| 67 | neurofilament cytoskeleton organization (GO:0060052) | 3.33994021 |
| 68 | regulation of vesicle fusion (GO:0031338) | 3.32597870 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.31220473 |
| 70 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.30660927 |
| 71 | fear response (GO:0042596) | 3.29230662 |
| 72 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.28393675 |
| 73 | regulation of synapse maturation (GO:0090128) | 3.27957386 |
| 74 | membrane depolarization (GO:0051899) | 3.27876829 |
| 75 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.27726842 |
| 76 | L-fucose catabolic process (GO:0042355) | 3.25120478 |
| 77 | fucose catabolic process (GO:0019317) | 3.25120478 |
| 78 | L-fucose metabolic process (GO:0042354) | 3.25120478 |
| 79 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.24381635 |
| 80 | positive regulation of neurotransmitter transport (GO:0051590) | 3.23831812 |
| 81 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.22268984 |
| 82 | learning (GO:0007612) | 3.21853066 |
| 83 | regulation of dendritic spine development (GO:0060998) | 3.21559198 |
| 84 | regulation of neurotransmitter transport (GO:0051588) | 3.19455243 |
| 85 | innervation (GO:0060384) | 3.19379082 |
| 86 | dendritic spine organization (GO:0097061) | 3.19288529 |
| 87 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.18852009 |
| 88 | primary amino compound metabolic process (GO:1901160) | 3.18344536 |
| 89 | neuromuscular process controlling balance (GO:0050885) | 3.17298485 |
| 90 | membrane hyperpolarization (GO:0060081) | 3.16439809 |
| 91 | auditory behavior (GO:0031223) | 3.15216297 |
| 92 | membrane depolarization during action potential (GO:0086010) | 3.14832993 |
| 93 | synapse assembly (GO:0007416) | 3.13752338 |
| 94 | startle response (GO:0001964) | 3.12385540 |
| 95 | long term synaptic depression (GO:0060292) | 3.12026247 |
| 96 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.11836143 |
| 97 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.11607496 |
| 98 | retinal cone cell development (GO:0046549) | 3.11403567 |
| 99 | neuromuscular synaptic transmission (GO:0007274) | 3.08943926 |
| 100 | activation of protein kinase A activity (GO:0034199) | 3.08403935 |
| 101 | synaptic transmission (GO:0007268) | 3.06928322 |
| 102 | regulation of synaptic transmission (GO:0050804) | 3.06403103 |
| 103 | response to amphetamine (GO:0001975) | 3.06355793 |
| 104 | positive regulation of dendritic spine development (GO:0060999) | 3.06161863 |
| 105 | regulation of glutamate secretion (GO:0014048) | 3.06106438 |
| 106 | cell migration in hindbrain (GO:0021535) | 3.05231714 |
| 107 | serotonin metabolic process (GO:0042428) | 3.03102513 |
| 108 | dendrite morphogenesis (GO:0048813) | 3.03101879 |
| 109 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.02578735 |
| 110 | short-term memory (GO:0007614) | 3.02076438 |
| 111 | positive regulation of synaptic transmission (GO:0050806) | 3.01150759 |
| 112 | intraspecies interaction between organisms (GO:0051703) | 3.00701884 |
| 113 | social behavior (GO:0035176) | 3.00701884 |
| 114 | synaptic transmission, cholinergic (GO:0007271) | 2.99421420 |
| 115 | DNA deamination (GO:0045006) | 2.98378429 |
| 116 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.97859541 |
| 117 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.97757689 |
| 118 | response to auditory stimulus (GO:0010996) | 2.97006804 |
| 119 | axon ensheathment in central nervous system (GO:0032291) | 2.93999154 |
| 120 | central nervous system myelination (GO:0022010) | 2.93999154 |
| 121 | cerebellum development (GO:0021549) | 2.92543992 |
| 122 | prepulse inhibition (GO:0060134) | 2.90592041 |
| 123 | neuronal ion channel clustering (GO:0045161) | 2.89576020 |
| 124 | spinal cord association neuron differentiation (GO:0021527) | 2.86320514 |
| 125 | chemosensory behavior (GO:0007635) | 2.84634136 |
| 126 | epithelial cilium movement (GO:0003351) | 2.82369242 |
| 127 | adult walking behavior (GO:0007628) | 2.74661352 |
| 128 | parturition (GO:0007567) | 2.71173805 |
| 129 | cytidine deamination (GO:0009972) | 2.70771227 |
| 130 | cytidine metabolic process (GO:0046087) | 2.70771227 |
| 131 | cytidine catabolic process (GO:0006216) | 2.70771227 |
| 132 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.69454182 |
| 133 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.66719688 |
| 134 | neuronal action potential (GO:0019228) | 2.65780630 |
| 135 | calcium ion-dependent exocytosis (GO:0017156) | 2.65713948 |
| 136 | behavioral response to ethanol (GO:0048149) | 2.64740518 |
| 137 | C4-dicarboxylate transport (GO:0015740) | 2.63146031 |
| 138 | adult behavior (GO:0030534) | 2.60003710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.43055992 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.86028739 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.24229642 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.19831477 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.11742851 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.79373109 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.78072344 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.78072344 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.72944452 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.71361144 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.63224722 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.60792075 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53937699 |
| 14 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.52750756 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.48856664 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46817702 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.37817369 |
| 18 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.27712554 |
| 19 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27545663 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.27378839 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.23690255 |
| 22 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.19945825 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.09530141 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.07560704 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.04544667 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.99396489 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.98912963 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.95314516 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.90514700 |
| 30 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83315014 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81683917 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.74442866 |
| 33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71739398 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.70847173 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68666088 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.60825952 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59020475 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.58873294 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58289004 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.52717838 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.50730687 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49551480 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47516847 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41633918 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40990046 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40020063 |
| 47 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35896112 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35864121 |
| 49 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.35474638 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33797230 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33727173 |
| 52 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.32581959 |
| 53 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30939497 |
| 54 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29321510 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29151671 |
| 56 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28201445 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27462756 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.26099134 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25596037 |
| 60 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25235433 |
| 61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24755283 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24217030 |
| 63 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.23004819 |
| 64 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22788215 |
| 65 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.22020779 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.20999306 |
| 67 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18855561 |
| 68 | AR_19668381_ChIP-Seq_PC3_Human | 1.18777784 |
| 69 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18691258 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17161018 |
| 71 | VDR_22108803_ChIP-Seq_LS180_Human | 1.16738300 |
| 72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16357020 |
| 73 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14271947 |
| 74 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.14201729 |
| 75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13800982 |
| 76 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.12486470 |
| 77 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.10504145 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10452693 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10323771 |
| 80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09672859 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09672859 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.06965818 |
| 83 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06533996 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06491758 |
| 85 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05419321 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05306971 |
| 87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04799620 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04487894 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04467511 |
| 90 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03302514 |
| 91 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03186083 |
| 92 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02978715 |
| 93 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02657859 |
| 94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02657859 |
| 95 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02461546 |
| 96 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02369342 |
| 97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01826219 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01172388 |
| 99 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.00666822 |
| 100 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00184221 |
| 101 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00131484 |
| 102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99455148 |
| 103 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97972210 |
| 104 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97972210 |
| 105 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97908360 |
| 106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97757701 |
| 107 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97387876 |
| 108 | JUN_21703547_ChIP-Seq_K562_Human | 0.97019535 |
| 109 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96518355 |
| 110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94171294 |
| 111 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.93823884 |
| 112 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93527576 |
| 113 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93525832 |
| 114 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93350890 |
| 115 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93200111 |
| 116 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93007935 |
| 117 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92053499 |
| 118 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.90709979 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90642529 |
| 120 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90510759 |
| 121 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90467343 |
| 122 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90395222 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88804940 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88298694 |
| 125 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88068324 |
| 126 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87498954 |
| 127 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87171319 |
| 128 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86793779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.37602092 |
| 2 | MP0003880_abnormal_central_pattern | 5.04197030 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.17619689 |
| 4 | MP0004270_analgesia | 3.71551341 |
| 5 | MP0009745_abnormal_behavioral_response | 3.51046706 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.44918509 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.18087086 |
| 8 | MP0002064_seizures | 3.13689669 |
| 9 | MP0009046_muscle_twitch | 3.11747521 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.94269267 |
| 11 | MP0002272_abnormal_nervous_system | 2.68284639 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.65340780 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.63351273 |
| 14 | MP0001486_abnormal_startle_reflex | 2.58024482 |
| 15 | MP0002736_abnormal_nociception_after | 2.57645959 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.51674368 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.47806841 |
| 18 | MP0002822_catalepsy | 2.31156911 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.27298087 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.11349986 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.07196581 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.05090495 |
| 23 | MP0000778_abnormal_nervous_system | 2.03174422 |
| 24 | MP0002184_abnormal_innervation | 2.02455940 |
| 25 | MP0001970_abnormal_pain_threshold | 1.95461334 |
| 26 | MP0002557_abnormal_social/conspecific_i | 1.87717591 |
| 27 | MP0001986_abnormal_taste_sensitivity | 1.85297844 |
| 28 | MP0004924_abnormal_behavior | 1.80558120 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.80558120 |
| 30 | MP0008569_lethality_at_weaning | 1.75486197 |
| 31 | MP0004811_abnormal_neuron_physiology | 1.73028741 |
| 32 | MP0002102_abnormal_ear_morphology | 1.72313052 |
| 33 | MP0008877_abnormal_DNA_methylation | 1.72024035 |
| 34 | MP0001984_abnormal_olfaction | 1.71010439 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.71000045 |
| 36 | MP0003329_amyloid_beta_deposits | 1.65704700 |
| 37 | MP0003879_abnormal_hair_cell | 1.61572821 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.56914230 |
| 39 | MP0003787_abnormal_imprinting | 1.55939956 |
| 40 | MP0001188_hyperpigmentation | 1.55282558 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.55206603 |
| 42 | MP0000955_abnormal_spinal_cord | 1.55032788 |
| 43 | MP0004858_abnormal_nervous_system | 1.48658376 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.46231395 |
| 45 | MP0001529_abnormal_vocalization | 1.43961110 |
| 46 | MP0002066_abnormal_motor_capabilities/c | 1.42821632 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.38263292 |
| 48 | MP0004142_abnormal_muscle_tone | 1.29560692 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.27531627 |
| 50 | MP0001905_abnormal_dopamine_level | 1.26385789 |
| 51 | MP0004885_abnormal_endolymph | 1.26107141 |
| 52 | MP0003136_yellow_coat_color | 1.26072966 |
| 53 | MP0009379_abnormal_foot_pigmentation | 1.18778166 |
| 54 | MP0005253_abnormal_eye_physiology | 1.15341577 |
| 55 | MP0002152_abnormal_brain_morphology | 1.15119164 |
| 56 | MP0003633_abnormal_nervous_system | 1.14275463 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.12021061 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.10529962 |
| 59 | MP0003121_genomic_imprinting | 1.08013593 |
| 60 | MP0003122_maternal_imprinting | 1.06278452 |
| 61 | MP0004145_abnormal_muscle_electrophysio | 1.05687105 |
| 62 | MP0003011_delayed_dark_adaptation | 1.05394136 |
| 63 | MP0004742_abnormal_vestibular_system | 1.04681306 |
| 64 | MP0002163_abnormal_gland_morphology | 1.02737928 |
| 65 | MP0003938_abnormal_ear_development | 1.02270478 |
| 66 | MP0003631_nervous_system_phenotype | 1.01316966 |
| 67 | MP0010386_abnormal_urinary_bladder | 0.98617063 |
| 68 | MP0008872_abnormal_physiological_respon | 0.95003093 |
| 69 | MP0002069_abnormal_eating/drinking_beha | 0.94601848 |
| 70 | MP0005394_taste/olfaction_phenotype | 0.93701119 |
| 71 | MP0005499_abnormal_olfactory_system | 0.93701119 |
| 72 | MP0002229_neurodegeneration | 0.92747284 |
| 73 | MP0002928_abnormal_bile_duct | 0.92281288 |
| 74 | MP0000751_myopathy | 0.92258630 |
| 75 | MP0004085_abnormal_heartbeat | 0.90392448 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 0.88602178 |
| 77 | MP0001963_abnormal_hearing_physiology | 0.88425809 |
| 78 | MP0002752_abnormal_somatic_nervous | 0.86506661 |
| 79 | MP0000631_abnormal_neuroendocrine_gland | 0.85597441 |
| 80 | MP0000538_abnormal_urinary_bladder | 0.84032444 |
| 81 | MP0001177_atelectasis | 0.83828952 |
| 82 | MP0000569_abnormal_digit_pigmentation | 0.82386750 |
| 83 | MP0008874_decreased_physiological_sensi | 0.81285990 |
| 84 | MP0005535_abnormal_body_temperature | 0.81098660 |
| 85 | MP0008789_abnormal_olfactory_epithelium | 0.77995085 |
| 86 | MP0004043_abnormal_pH_regulation | 0.77633682 |
| 87 | MP0003123_paternal_imprinting | 0.77551778 |
| 88 | MP0002160_abnormal_reproductive_system | 0.76735391 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.76584221 |
| 90 | MP0004147_increased_porphyrin_level | 0.76186473 |
| 91 | MP0002876_abnormal_thyroid_physiology | 0.74725832 |
| 92 | MP0003632_abnormal_nervous_system | 0.73787467 |
| 93 | MP0004215_abnormal_myocardial_fiber | 0.73663143 |
| 94 | MP0004484_altered_response_of | 0.73348375 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.72812697 |
| 96 | MP0003890_abnormal_embryonic-extraembry | 0.71693198 |
| 97 | MP0005187_abnormal_penis_morphology | 0.71225555 |
| 98 | MP0005195_abnormal_posterior_eye | 0.71168703 |
| 99 | MP0005389_reproductive_system_phenotype | 0.69813483 |
| 100 | MP0005409_darkened_coat_color | 0.69685373 |
| 101 | MP0003634_abnormal_glial_cell | 0.69658600 |
| 102 | MP0005379_endocrine/exocrine_gland_phen | 0.69424656 |
| 103 | MP0004233_abnormal_muscle_weight | 0.67304881 |
| 104 | MP0000013_abnormal_adipose_tissue | 0.66623911 |
| 105 | MP0003861_abnormal_nervous_system | 0.66013421 |
| 106 | MP0001485_abnormal_pinna_reflex | 0.65674878 |
| 107 | MP0001664_abnormal_digestion | 0.65390534 |
| 108 | MP0000604_amyloidosis | 0.63149871 |
| 109 | MP0004133_heterotaxia | 0.63017242 |
| 110 | MP0005410_abnormal_fertilization | 0.62722889 |
| 111 | MP0003137_abnormal_impulse_conducting | 0.62310276 |
| 112 | MP0000427_abnormal_hair_cycle | 0.61689633 |
| 113 | MP0006292_abnormal_olfactory_placode | 0.60616876 |
| 114 | MP0005084_abnormal_gallbladder_morpholo | 0.60042767 |
| 115 | MP0001943_abnormal_respiration | 0.60020134 |
| 116 | MP0000026_abnormal_inner_ear | 0.59295579 |
| 117 | MP0008961_abnormal_basal_metabolism | 0.58338997 |
| 118 | MP0002090_abnormal_vision | 0.58199350 |
| 119 | MP0003075_altered_response_to | 0.58058864 |
| 120 | MP0010769_abnormal_survival | 0.54090708 |
| 121 | MP0002082_postnatal_lethality | 0.53564983 |
| 122 | MP0010770_preweaning_lethality | 0.53564983 |
| 123 | MP0002653_abnormal_ependyma_morphology | 0.52413470 |
| 124 | MP0010768_mortality/aging | 0.51530731 |
| 125 | MP0002751_abnormal_autonomic_nervous | 0.50701224 |
| 126 | MP0006072_abnormal_retinal_apoptosis | 0.50370324 |
| 127 | MP0003956_abnormal_body_size | 0.48696988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.34399111 |
| 2 | Myokymia (HP:0002411) | 6.44595248 |
| 3 | Focal seizures (HP:0007359) | 6.02324453 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.66247136 |
| 5 | Visual hallucinations (HP:0002367) | 5.27557579 |
| 6 | Atonic seizures (HP:0010819) | 5.04303597 |
| 7 | Febrile seizures (HP:0002373) | 5.02380025 |
| 8 | Absence seizures (HP:0002121) | 4.67066961 |
| 9 | Hyperventilation (HP:0002883) | 4.39420512 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 4.39403487 |
| 11 | Dialeptic seizures (HP:0011146) | 4.26482887 |
| 12 | Broad-based gait (HP:0002136) | 4.03623893 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 4.01573048 |
| 14 | Poor eye contact (HP:0000817) | 3.63014177 |
| 15 | Action tremor (HP:0002345) | 3.56681636 |
| 16 | Amblyopia (HP:0000646) | 3.53774634 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 3.44896024 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 3.26437494 |
| 19 | Dysdiadochokinesis (HP:0002075) | 3.18784224 |
| 20 | Abnormal social behavior (HP:0012433) | 3.18782743 |
| 21 | Impaired social interactions (HP:0000735) | 3.18782743 |
| 22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.07695038 |
| 23 | Drooling (HP:0002307) | 3.07302193 |
| 24 | Excessive salivation (HP:0003781) | 3.07302193 |
| 25 | Truncal ataxia (HP:0002078) | 3.07266189 |
| 26 | Congenital stationary night blindness (HP:0007642) | 3.06606765 |
| 27 | Anxiety (HP:0000739) | 2.92789979 |
| 28 | Abnormal pancreas size (HP:0012094) | 2.92754964 |
| 29 | Molar tooth sign on MRI (HP:0002419) | 2.92602184 |
| 30 | Abnormality of midbrain morphology (HP:0002418) | 2.92602184 |
| 31 | Depression (HP:0000716) | 2.92164858 |
| 32 | Pancreatic cysts (HP:0001737) | 2.91972444 |
| 33 | Epileptiform EEG discharges (HP:0011182) | 2.86855861 |
| 34 | Dysmetria (HP:0001310) | 2.86418947 |
| 35 | Mutism (HP:0002300) | 2.79326294 |
| 36 | Chronic hepatic failure (HP:0100626) | 2.73912722 |
| 37 | Nephronophthisis (HP:0000090) | 2.73774220 |
| 38 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.73558353 |
| 39 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.72991606 |
| 40 | Pancreatic fibrosis (HP:0100732) | 2.72712797 |
| 41 | Absent speech (HP:0001344) | 2.71412210 |
| 42 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.70832292 |
| 43 | Ankle clonus (HP:0011448) | 2.68914209 |
| 44 | Hemiparesis (HP:0001269) | 2.68736063 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.67918439 |
| 46 | Abnormal eating behavior (HP:0100738) | 2.67684277 |
| 47 | Abnormality of the lower motor neuron (HP:0002366) | 2.66963334 |
| 48 | Medial flaring of the eyebrow (HP:0010747) | 2.65103888 |
| 49 | EEG with generalized epileptiform discharges (HP:0011198) | 2.64339749 |
| 50 | Diplopia (HP:0000651) | 2.63630383 |
| 51 | Abnormality of binocular vision (HP:0011514) | 2.63630383 |
| 52 | Type II lissencephaly (HP:0007260) | 2.62501201 |
| 53 | Genetic anticipation (HP:0003743) | 2.61872221 |
| 54 | Cerebral inclusion bodies (HP:0100314) | 2.58404905 |
| 55 | Inability to walk (HP:0002540) | 2.57307670 |
| 56 | Stereotypic behavior (HP:0000733) | 2.55946625 |
| 57 | Scanning speech (HP:0002168) | 2.54708879 |
| 58 | Abnormal drinking behavior (HP:0030082) | 2.52671362 |
| 59 | Polydipsia (HP:0001959) | 2.52671362 |
| 60 | Fetal akinesia sequence (HP:0001989) | 2.51443382 |
| 61 | True hermaphroditism (HP:0010459) | 2.47276756 |
| 62 | Progressive inability to walk (HP:0002505) | 2.44559892 |
| 63 | Protruding tongue (HP:0010808) | 2.44484703 |
| 64 | Hypsarrhythmia (HP:0002521) | 2.44291377 |
| 65 | Urinary urgency (HP:0000012) | 2.43432820 |
| 66 | Postural instability (HP:0002172) | 2.40419874 |
| 67 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.39332154 |
| 68 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.39332154 |
| 69 | Dysmetric saccades (HP:0000641) | 2.33684652 |
| 70 | Abnormality of the renal medulla (HP:0100957) | 2.33569600 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.32251305 |
| 72 | Limb dystonia (HP:0002451) | 2.31859986 |
| 73 | Thyroid-stimulating hormone excess (HP:0002925) | 2.31026143 |
| 74 | Acute necrotizing encephalopathy (HP:0006965) | 2.31000828 |
| 75 | Optic nerve hypoplasia (HP:0000609) | 2.29886076 |
| 76 | Status epilepticus (HP:0002133) | 2.29832715 |
| 77 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.29241710 |
| 78 | Torticollis (HP:0000473) | 2.29235904 |
| 79 | Insidious onset (HP:0003587) | 2.26593680 |
| 80 | Termporal pattern (HP:0011008) | 2.26593680 |
| 81 | Decreased circulating renin level (HP:0003351) | 2.26422177 |
| 82 | Mitochondrial inheritance (HP:0001427) | 2.24084212 |
| 83 | Spastic gait (HP:0002064) | 2.23232608 |
| 84 | Bradykinesia (HP:0002067) | 2.22920865 |
| 85 | Abnormality of the corticospinal tract (HP:0002492) | 2.22545699 |
| 86 | Generalized myoclonic seizures (HP:0002123) | 2.22238168 |
| 87 | Progressive macrocephaly (HP:0004481) | 2.22236020 |
| 88 | Focal dystonia (HP:0004373) | 2.20707246 |
| 89 | Absent/shortened dynein arms (HP:0200106) | 2.19860259 |
| 90 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19860259 |
| 91 | Papilledema (HP:0001085) | 2.17112872 |
| 92 | Abolished electroretinogram (ERG) (HP:0000550) | 2.11808000 |
| 93 | Hemiplegia (HP:0002301) | 2.09990693 |
| 94 | Cystic liver disease (HP:0006706) | 2.08075810 |
| 95 | Amyotrophic lateral sclerosis (HP:0007354) | 2.08069792 |
| 96 | Incomplete penetrance (HP:0003829) | 2.08046442 |
| 97 | Abnormality of the renal cortex (HP:0011035) | 2.07778481 |
| 98 | Retinal dysplasia (HP:0007973) | 2.07658611 |
| 99 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.06001446 |
| 100 | Polyuria (HP:0000103) | 2.05529719 |
| 101 | Impaired vibratory sensation (HP:0002495) | 2.05344432 |
| 102 | Decreased central vision (HP:0007663) | 2.04780799 |
| 103 | Inappropriate behavior (HP:0000719) | 2.03055334 |
| 104 | Abnormality of salivation (HP:0100755) | 2.02999210 |
| 105 | Blue irides (HP:0000635) | 2.02784398 |
| 106 | Polyphagia (HP:0002591) | 2.01301718 |
| 107 | Congenital primary aphakia (HP:0007707) | 2.00954582 |
| 108 | Annular pancreas (HP:0001734) | 2.00897486 |
| 109 | Abnormal ciliary motility (HP:0012262) | 1.98900610 |
| 110 | Gait imbalance (HP:0002141) | 1.98063838 |
| 111 | Delusions (HP:0000746) | 1.97781619 |
| 112 | Intention tremor (HP:0002080) | 1.97494485 |
| 113 | Gait ataxia (HP:0002066) | 1.97414047 |
| 114 | Metabolic alkalosis (HP:0200114) | 1.97292720 |
| 115 | Megalencephaly (HP:0001355) | 1.96846530 |
| 116 | Optic disc pallor (HP:0000543) | 1.93882499 |
| 117 | Increased CSF lactate (HP:0002490) | 1.93426091 |
| 118 | Attenuation of retinal blood vessels (HP:0007843) | 1.92895177 |
| 119 | Pheochromocytoma (HP:0002666) | 1.92807587 |
| 120 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.92608472 |
| 121 | Craniofacial dystonia (HP:0012179) | 1.91592233 |
| 122 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.91246618 |
| 123 | Nephrogenic diabetes insipidus (HP:0009806) | 1.89908129 |
| 124 | Lower limb muscle weakness (HP:0007340) | 1.89619541 |
| 125 | Pachygyria (HP:0001302) | 1.86141917 |
| 126 | Specific learning disability (HP:0001328) | 1.85180394 |
| 127 | Lower limb asymmetry (HP:0100559) | 1.84353999 |
| 128 | Vaginal atresia (HP:0000148) | 1.81746697 |
| 129 | Lissencephaly (HP:0001339) | 1.80789174 |
| 130 | Dyskinesia (HP:0100660) | 1.80781804 |
| 131 | Agitation (HP:0000713) | 1.80113767 |
| 132 | Hypothermia (HP:0002045) | 1.80056960 |
| 133 | Genital tract atresia (HP:0001827) | 1.79550187 |
| 134 | Cerebral hypomyelination (HP:0006808) | 1.78847184 |
| 135 | Obstructive sleep apnea (HP:0002870) | 1.78340370 |
| 136 | Pointed chin (HP:0000307) | 1.78148680 |
| 137 | Hypoplasia of the brainstem (HP:0002365) | 1.77330199 |
| 138 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.77330199 |
| 139 | Tubular atrophy (HP:0000092) | 1.77245970 |
| 140 | Spastic tetraplegia (HP:0002510) | 1.76034618 |
| 141 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.75767994 |
| 142 | Sclerocornea (HP:0000647) | 1.75737404 |
| 143 | Acute encephalopathy (HP:0006846) | 1.75633784 |
| 144 | Widely spaced teeth (HP:0000687) | 1.75427315 |
| 145 | Hyperthyroidism (HP:0000836) | 1.75409400 |
| 146 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.75053754 |
| 147 | Psychosis (HP:0000709) | 1.74713793 |
| 148 | Oligodactyly (hands) (HP:0001180) | 1.74563397 |
| 149 | Hepatocellular necrosis (HP:0001404) | 1.74448312 |
| 150 | Autism (HP:0000717) | 1.72585479 |
| 151 | Akinesia (HP:0002304) | 1.72496585 |
| 152 | Generalized hypopigmentation of hair (HP:0011358) | 1.71682992 |
| 153 | Exotropia (HP:0000577) | 1.70938229 |
| 154 | Ventricular fibrillation (HP:0001663) | 1.70736336 |
| 155 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.70331218 |
| 156 | Neuroendocrine neoplasm (HP:0100634) | 1.66584963 |
| 157 | Aqueductal stenosis (HP:0002410) | 1.64560463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.60769406 |
| 2 | EPHA4 | 4.53856879 |
| 3 | MAP3K9 | 3.59901763 |
| 4 | FRK | 3.59891979 |
| 5 | MARK1 | 3.14569133 |
| 6 | MAP3K4 | 3.07656952 |
| 7 | DAPK2 | 2.75040554 |
| 8 | MINK1 | 2.74753890 |
| 9 | MAP2K7 | 2.74689015 |
| 10 | RIPK4 | 2.64990701 |
| 11 | CASK | 2.59829932 |
| 12 | ADRBK2 | 2.59256761 |
| 13 | MAP3K12 | 2.19051549 |
| 14 | PAK6 | 2.05454412 |
| 15 | MAP2K4 | 2.01656193 |
| 16 | WNK4 | 1.99994187 |
| 17 | TXK | 1.92590039 |
| 18 | DAPK1 | 1.89959160 |
| 19 | KSR1 | 1.88783026 |
| 20 | KSR2 | 1.88606467 |
| 21 | NTRK2 | 1.87544696 |
| 22 | PLK2 | 1.85943914 |
| 23 | PNCK | 1.80555798 |
| 24 | SIK2 | 1.68191814 |
| 25 | BMPR1B | 1.59398848 |
| 26 | CDK19 | 1.51730878 |
| 27 | GRK1 | 1.45918020 |
| 28 | CDK5 | 1.45777284 |
| 29 | TNIK | 1.45469295 |
| 30 | CAMKK1 | 1.45317027 |
| 31 | GRK5 | 1.43390661 |
| 32 | MAPK13 | 1.42310100 |
| 33 | PRPF4B | 1.42093116 |
| 34 | MAP4K2 | 1.42004776 |
| 35 | NTRK1 | 1.34252840 |
| 36 | TLK1 | 1.32968288 |
| 37 | ARAF | 1.24930512 |
| 38 | PRKCG | 1.24397586 |
| 39 | BMPR2 | 1.24173467 |
| 40 | PRKD3 | 1.15941942 |
| 41 | DYRK2 | 1.15595638 |
| 42 | MAP3K13 | 1.15452188 |
| 43 | FES | 1.11195098 |
| 44 | CAMK2A | 1.10803025 |
| 45 | SIK3 | 1.09707302 |
| 46 | CAMKK2 | 1.08139862 |
| 47 | STK38 | 1.06489963 |
| 48 | INSRR | 1.05515117 |
| 49 | CCNB1 | 1.05171804 |
| 50 | PTK2B | 1.01588680 |
| 51 | UHMK1 | 1.01229722 |
| 52 | BCKDK | 0.95510969 |
| 53 | TYRO3 | 0.94819296 |
| 54 | MAP3K2 | 0.89133707 |
| 55 | CAMK2B | 0.88499841 |
| 56 | CDK18 | 0.88101705 |
| 57 | ZAK | 0.87069757 |
| 58 | CDK14 | 0.85684985 |
| 59 | TRIM28 | 0.83357145 |
| 60 | CDK15 | 0.83105624 |
| 61 | CAMK1 | 0.82779440 |
| 62 | LATS2 | 0.81777203 |
| 63 | SGK223 | 0.81607984 |
| 64 | SGK494 | 0.81607984 |
| 65 | CSNK1G3 | 0.80981900 |
| 66 | DYRK1A | 0.79109840 |
| 67 | RAF1 | 0.77253115 |
| 68 | NME1 | 0.77017339 |
| 69 | STK39 | 0.75876197 |
| 70 | SGK2 | 0.75709206 |
| 71 | PHKG1 | 0.74360800 |
| 72 | PHKG2 | 0.74360800 |
| 73 | STK11 | 0.73857728 |
| 74 | CSNK1G2 | 0.72978198 |
| 75 | CDK11A | 0.72317333 |
| 76 | OXSR1 | 0.71516824 |
| 77 | SGK1 | 0.68567267 |
| 78 | CSNK1G1 | 0.67076226 |
| 79 | PRKCQ | 0.66590822 |
| 80 | NUAK1 | 0.65448574 |
| 81 | ITK | 0.65292123 |
| 82 | MAPKAPK5 | 0.65070963 |
| 83 | PINK1 | 0.65009703 |
| 84 | AKT3 | 0.64309322 |
| 85 | FGR | 0.64062718 |
| 86 | RET | 0.63646528 |
| 87 | PAK3 | 0.61824050 |
| 88 | MAP3K6 | 0.60644200 |
| 89 | MARK2 | 0.60304696 |
| 90 | PRKCI | 0.60142104 |
| 91 | CSNK1A1L | 0.59448576 |
| 92 | PRKCE | 0.57070462 |
| 93 | PRKCA | 0.55823642 |
| 94 | ERBB2 | 0.55143953 |
| 95 | CSNK1A1 | 0.54443864 |
| 96 | PRKCZ | 0.53015148 |
| 97 | PKN1 | 0.52380793 |
| 98 | TAOK1 | 0.51310289 |
| 99 | WNK3 | 0.50597978 |
| 100 | BCR | 0.50306604 |
| 101 | ACVR1B | 0.48768706 |
| 102 | SGK3 | 0.48461282 |
| 103 | TNK2 | 0.48076728 |
| 104 | WNK1 | 0.47272503 |
| 105 | MAPK12 | 0.46366133 |
| 106 | EPHB2 | 0.46292248 |
| 107 | ERBB3 | 0.45615948 |
| 108 | PRKCH | 0.45433575 |
| 109 | CAMK2D | 0.45169546 |
| 110 | FER | 0.45002237 |
| 111 | PIK3CA | 0.44896603 |
| 112 | MAP2K1 | 0.44583228 |
| 113 | LIMK1 | 0.44457403 |
| 114 | PDK1 | 0.43810852 |
| 115 | MAP2K6 | 0.43207224 |
| 116 | DAPK3 | 0.41294719 |
| 117 | RPS6KA3 | 0.41034282 |
| 118 | PDPK1 | 0.40643460 |
| 119 | CAMK2G | 0.40216878 |
| 120 | CAMK1G | 0.39808205 |
| 121 | FGFR2 | 0.39445527 |
| 122 | FYN | 0.39213489 |
| 123 | MAP2K2 | 0.39124731 |
| 124 | PRKG1 | 0.38637640 |
| 125 | CAMK4 | 0.38551262 |
| 126 | BRAF | 0.38242681 |
| 127 | ALK | 0.37610536 |
| 128 | MAP3K1 | 0.37274328 |
| 129 | SYK | 0.36875152 |
| 130 | CSNK1D | 0.36143009 |
| 131 | GRK7 | 0.34631724 |
| 132 | CHUK | 0.34173510 |
| 133 | MAPK10 | 0.33362231 |
| 134 | PRKACA | 0.30628418 |
| 135 | ADRBK1 | 0.30574144 |
| 136 | PRKCB | 0.29394839 |
| 137 | MUSK | 0.29198950 |
| 138 | NEK6 | 0.28536257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.13735823 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.34393519 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.90047265 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.86498535 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.75860842 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.75359459 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.66696599 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.62530841 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.62322675 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.59239548 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.26972509 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.20501809 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.08361075 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.01896932 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.93605033 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.90924393 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.88849101 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.88363493 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87289484 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.82001859 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.79210433 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.76290455 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.75104413 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.71249533 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.64414706 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63039005 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59815688 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45253708 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44464476 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.37656392 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33592190 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33425054 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29346724 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27192519 |
| 35 | Axon guidance_Homo sapiens_hsa04360 | 1.24593116 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.22883552 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22442779 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16408826 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16086078 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13264789 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.11150492 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10891166 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.09967156 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.09203568 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07295185 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06230917 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05806993 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 1.04674157 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02937205 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02827635 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02539493 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97571730 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93158546 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.92724786 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92351780 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91722015 |
| 57 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.90190726 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89447106 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84640190 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82601125 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.79118131 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77971638 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74106080 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73326701 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70520758 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70221944 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70098898 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68854041 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68702390 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68019567 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67768747 |
| 72 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67019145 |
| 73 | Protein export_Homo sapiens_hsa03060 | 0.65452366 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.64313866 |
| 75 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62037622 |
| 76 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61027924 |
| 77 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.59306461 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58089344 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56534081 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55094884 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54571017 |
| 82 | Alcoholism_Homo sapiens_hsa05034 | 0.53306310 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52160705 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50479300 |
| 85 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.50174658 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49669948 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.48004055 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47784520 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47510926 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47088975 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46681895 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46678001 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46610260 |
| 94 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.44945391 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44541613 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43453441 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42814307 |
| 98 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41947351 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.40586431 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38794605 |
| 101 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38502578 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37767043 |
| 103 | Asthma_Homo sapiens_hsa05310 | 0.37694835 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37659785 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37555954 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35679337 |
| 107 | RNA polymerase_Homo sapiens_hsa03020 | 0.35437013 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35135983 |
| 109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34782894 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32300062 |
| 111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31774890 |
| 112 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31296567 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30724015 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.29985377 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.29727634 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.29359844 |
| 117 | Allograft rejection_Homo sapiens_hsa05330 | 0.28765331 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.27973657 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27953327 |
| 120 | Huntingtons disease_Homo sapiens_hsa05016 | 0.27820812 |
| 121 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.27319908 |
| 122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.26699925 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.26326219 |
| 124 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.26197371 |
| 125 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26155002 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25538288 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24848875 |
| 128 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24644419 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.23276444 |
| 130 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.23240475 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22513773 |
| 132 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22459095 |

